{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:59:25Z","timestamp":1793145565698,"version":"4.5.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1097\/pas.0b013e3181868904","type":"journal-article","created":{"date-parts":[[2009,2,23]],"date-time":"2009-02-23T08:22:57Z","timestamp":1235377377000},"page":"376-383","source":"Crossref","is-referenced-by-count":114,"title":["Serous Tubal Intraepithelial Carcinoma and the Dominant Ovarian Mass"],"prefix":"10.1097","volume":"33","author":[{"given":"Michael H.","family":"Roh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kindelberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Crum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210131","first-page":"206","article-title":"Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours","author":"Alvarado-Cabrero","year":"2003"},{"key":"R2-6-20210131","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/1097-0142(20000715)89:2<383::AID-CNCR25>3.0.CO;2-T","article-title":"Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes","volume":"89","author":"Barakat","year":"2000","journal-title":"Cancer"},{"key":"R3-6-20210131","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L","article-title":"Early de novo ovarian carcinoma. A study of fourteen cases","volume":"73","author":"Bell","year":"1994","journal-title":"Cancer"},{"key":"R4-6-20210131","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R5-6-20210131","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"R6-6-20210131","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/01.pas.0000202161.80739.ac","article-title":"Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature","volume":"30","author":"Carcangiu","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R9-6-20210131","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.AOG.0000187892.78392.3f","article-title":"BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?","volume":"106","author":"Cass","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R10-6-20210131","first-page":"698","article-title":"Diagnostic Gynecologic and Obstetric Pathology","author":"Chang","year":"2006"},{"key":"R11-6-20210131","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/01.pgp.0000235065.31301.3e","article-title":"Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma","volume":"26","author":"Chiesa-Vottero","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"R12-6-20210131","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R13-6-20210131","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R14-6-20210131","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1544::AID-CNCR22>3.0.CO;2-I","article-title":"Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations","volume":"86","author":"Deligdisch","year":"1999","journal-title":"Cancer"},{"key":"R15-6-20210131","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R16-6-20210131","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with heterozygous BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R17-6-20210131","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0090-8258(02)00104-X","article-title":"Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach","volume":"88","author":"Horiuchi","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R18-6-20210131","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2559.1995.tb01528.x","article-title":"p53 protein expression in putative precursor lesions of epithelial ovarian cancer","volume":"27","author":"Hutson","year":"1995","journal-title":"Histopathology"},{"key":"R19-6-20210131","first-page":"161","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"31","author":"Jarboe","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"R20-6-20210131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"R21-6-20210131","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R22-6-20210131","first-page":"119","article-title":"Tumours of the Breast and Female Genital Organs","author":"Lee","year":"2003"},{"key":"R23-6-20210131","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"R24-6-20210131","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1200\/JCO.2003.04.131","article-title":"Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations","volume":"21","author":"Levine","year":"2003","journal-title":"J Clin Oncol"},{"key":"R25-6-20210131","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familiar ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R26-6-20210131","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00004347-200210000-00010","article-title":"Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study","volume":"21","author":"Mhawech","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R27-6-20210131","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1365-2559.2007.02682.x","article-title":"High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour","volume":"50","author":"O'Neill","year":"2007","journal-title":"Histopathology"},{"key":"R28-6-20210131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0301-2115(03)00047-2","article-title":"Prevalence of endometriosis in malignant epithelial ovary tumours","volume":"109","author":"Oral","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R29-6-20210131","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.6071","article-title":"Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis","volume":"80","author":"Paley","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R30-6-20210131","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ajog.2004.02.067","article-title":"Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause","volume":"191","author":"Piek","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R31-6-20210131","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"J Clin Oncol"},{"key":"R32-6-20210131","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R33-6-20210131","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis","volume":"29","author":"Singer","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R34-6-20210131","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.pgp.0000101083.35393.cd","article-title":"Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry","volume":"23","author":"Werness","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R35-6-20210131","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.1999.5623","article-title":"Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations","volume":"76","author":"Zweemer","year":"2000","journal-title":"Gynecol Oncol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0b013e3181868904","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:54:49Z","timestamp":1620968089000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-200903000-00006"}},"subtitle":["Clues to Serous Tumor Origin?"],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e3181868904","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}